II. Epidemiology
- Most common vector-borne Arbovirus in United States (as of 2016)- Reported cases: ~50,000 between 1999 and 2018
 
- Most severe illness occurs in older patients- Over age 50: Twenty fold risk of severe illness
 
- Timing- Temperate climate: Late summer and early fall- Range of infections: Mid-July to early December
- Peaks in late August to early September
 
- Southern climate: Year round transmission
- Most favorable weather conditions- Hot,dry summer with brief unseasonably cool weather
 
 
- Temperate climate: Late summer and early fall
- Distribution- Africa- First identified in Uganda's West Nile Province (1937)
 
- West Asia
- Eastern Europe
- Middle East
- United States (as of 1999)- Queens, New York outbreak (1999)
- Central States
- Great Plains States
 
 
- Africa
III. Pathophysiology
- Arbovirus (Arthopod-borne)
- 
                          Flaviviridae (Flavivirus) family- Flaviviridae are transmitted by arthropods (Group B Arbovirus, ticks or Mosquitos)
- Flaviviridae are enveloped, Icosahedral single stranded RNA Viruses
- Flaviviridae are Message Sense RNA Viruses (Positive Stranded, +ssRNA)- Message sense RNA (+ssRNA) are identical to Messenger RNA (mRNA)
- Like mRNA, +ssRNA may be immediately translated by host ribosomes into Protein
 
 
- Humans are incidental hosts- Typically cycles between birds, Mosquitos and then back to birds
 
- Transmission- Most commonly by Mosquito Bite
- Organ transplant or Blood Transfusion (screened in U.S. before transplant or transfusion)
- Transplacental transmission
 
- Incubation: 3-14 days
- Animals affected- Wild birds are usual hosts- Dead birds may suggest endemic area
- Corvids (Crows and Jays) are most often affected
 
- Horses are most affected domesticated animals
- Cats
- Bats
- Chipmunks
- Skunks
- Squirrels
- Rabbits
 
- Wild birds are usual hosts
IV. Types
- Asymptomatic Infection (80%)- Majority of children are asymptomatic or have mild symptoms
 
- West Nile Fever (WNF, 20%)
- West Nile Neuroinvasive Disease (WNND, 1%)- Meningitis or Encephalitis
- More severe cases occur in older adults
- Risk Factors- Age over 50 years old
- Diabetes Mellitus
- Alcohol Abuse
- Male gender
- Organ transplant or Immunosuppression
- Autoimmune Disease
 
 
V. Symptoms: West Nile Fever
- Spectrum of disease- See Types above
 
- Symptoms (abrupt onset without prodrome): Flu-like illness- Fever up to 40 Celsius
- Malaise
- Muscle Weakness to Flaccid Paralysis
- Profound Fatigue (may persist for weeks)
- Chills and myalgias (e.g. back pain)
- Drowsiness or lethargy
 
- Variable symptoms
- Rare Symptoms- Abdominal Pain (if hepatitis or Pancreatitis)
 
- Classic presentation- Late summer, early fall onset of Prolonged Fever and neurologic symptoms
 
VI. Signs: West Nile Fever
- Non-tender Generalized Lymphadenopathy- Occipital Lymphadenopathy
- Axillary Lymphadenopathy
- Inguinal Lymphadenopathy
- Lymphadenopathy may persist for months
 
- Facial Flushing
- Conjunctival injection
- Coating of Tongue
- Pale maculopapular rash (Roseola-like)- Affects trunk and upper arms
- Onset on days 2 to 5 (typically as fever subsides)
 
VII. Signs: Neurologic signs (West Nile Neuroinvasive Disease or WNND)
- No sensory deficits
- Motor Findings (Polio-like syndrome or similar to Guillain-Barre Syndrome)- Severe Muscle Weakness to Acute Flaccid Paralysis or Myelitis (related to anterior horn cell involvement)
- Polyradiculitis
- Myoclonus
- Decreased or absent Deep Tendon Reflexes
- Myelitis
 
- 
                          Cranial Nerve findings- Cranial Nerve abnormalities
- Optic Neuritis
 
- MIscellaneous findings
VIII. Differential Diagnosis
- See Viral Encephalitis
- St. Louis Encephalitis
- Dengue
IX. Labs: General
- Metabolic panel- Hyponatremia may occur with Encephalitis
 
- 
                          Complete Blood Count (CBC)- Leukopenia (Leukocytes <4000/mm3)
- Mild Leukocytosis may also occur
 
- 
                          Lumbar Puncture
                          - Initial Neutrophilia, then Lymphocytosis
- Normal CSF Glucose
- Mild increases in CSF Protein concentration
 
X. Labs: Diagnosis
- West Nile Virus serum or CSF IgM by MAC-ELISA (preferred)- Best lab test for diagnosis (95% sensitive)
- Collect 8-21 days after onset of symptoms (False Negative in first 7 days)
- Positive CSF IgM confirms CNS Infection
- False Positives due to cross reactivity- St. Louis Encephalitis virus
- FlavivirusVaccine (e.g. Yellow Fever, Dengue)
- Prior West Nile Virus (CSF IgM may persist for >1 years from prior infection)
 
 
- Other testing (not used routinely)- Blood isolation of virus- Sensitivity on Day 1: 75% of cases positive
- Sensitivity decreases over first 5 infection days
 
- CSF Testing- CSF Viral culture
- CSF West Nile PCR- Low Test Sensitivity as CSF (and blood) have often been cleared of Antigen by time of diagnostics
- May be associated with worse prognosis when present
 
 
 
- Blood isolation of virus
XI. Imaging
- 
                          MRI Brain
                          - Abnormal in 25-35% of cases
- Nonspecific findings (esp. in Thalamus, Basal Ganglia)
 
XII. Complications
- Neurologic disease (one in 30-70 cases, some studies report 1 in 150 cases)- Meningitis
- Encephalitis
- West Nile Poliomyelitis-like syndrome- Asymmetric Flaccid Paralysis (may include respiratory Muscles)
 
- Guillain-Barre Syndrome
- Extrapyramidal symptoms
- Long-term neuropsychiatric sequelae- Fatigue
- Memory Loss
- Difficulty walking
- Muscle Weakness
- Major Depression
 
 
- Other complications (rare)- Myocarditis
- Chorioretinitis
- Cardiac Arrhythmias
- Pancreatitis
- Hepatitis
- Rhabdomyolysis
 
XIII. Management
- Supportive care in most cases- Hydration
- Analgesia
 
- Investigational agents to consider in severe cases
XIV. Prognosis
- Most Mosquitos in endemic areas are not infected
- If infection occurs, 99% of cases are self-limited
- Severe cases (meningoencephalitis) occur in less than 1-2% of infections- Mortality in severe cases is 5-15% (up to 30% in some cohorts)
- Elderly account for majority of fatal cases
- Immunocompromised patients also have a worse prognosis
 
XV. Course
- Incubation up to 6 days
- Duration for 3 to 5 days in 80% of cases
- Prolonged recovery may take up to one year to return to full functional and cognitive capacity- Fatigue may take weeks to months or longer for resolution
- Up to 50% of patients have persistent symptoms and functional Impairment at >1.5 years
- More prolonged course with West Nile Neuroinvasive Disease (WNND)
 
XVI. Prevention
- See Prevention of Vector-borne Infection (includes Insect Repellent, esp. DEET)
- Eliminate areas of standing water (and other Mosquito control)
- No available Vaccination
- Blood donor screening
XVII. Resources
- CDC West Nile Virus
XVIII. References
- Della-Giustina, Fox and Siegel (2021) Crit Dec Emerg Med 35(4): 17-23
- Douglas in Goldman (2000) Cecil Medicine, p. 1851
- Huhn (2003) Am Fam Physician 68(4):653-72 [PubMed]
- Huntington (2016) Am Fam Physician 94(7): 551-7 [PubMed]
- Nash (2001) N Engl J Med 3441:1807-1814 [PubMed]
- Petersen (2002) Ann Intern Med 137:173-9 [PubMed]
